30th August 2023
Linesight was engaged by one of the leading biopharmaceutical companies to provide full cost management services for the construction of its new pharmaceutical manufacturing facility in Shanghai. The 100,000 sq.m. facility of our confidential client is dedicated to the production of mRNA vaccines in China.
Linesight established a secondary review system to ensure that cost controls for accurate payment assessments were in place throughout the duration of the project. We conducted a secondary assessment of the costs, which involved procurement, change management and final account reviews. The team also delivered a comprehensive cost report with findings and recommendations to help deliver the project within budget.
In addition, our team reviewed the client’s policies and procedures to ensure compliance to governance requirements, such as anti-bribery and corruption, discrimination and environmental clauses.
Data
Garvan Barry
Regional Director, North Asia
MENA
Relevant Projects
Latest Insights
20th November 2024
Construction Market Insights H2 2024 – Americas
While both the US and Canadian economies are expected to grow steadily in 2024, the construction markets in these two countries are following divergent trends.
Continue Reading20 November 2024
Construction Market Insights H2 2024 – Europe
20 November 2024
Construction Market Insights H2 2024 – APAC & GCC